19 June 2013
Keywords: Spain, Pricing pressure, Public health debt to pharma, Almirall, Zeltia, Grifols
Article | 13 March 2013
The pressure on the prices of medicines by Spanish government has seen the pharmaceutical market in Spain declined more than 7% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 March 2013
© 2013 thepharmaletter.com